1. Home
  2. NB vs ALEC Comparison

NB vs ALEC Comparison

Compare NB & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NB
  • ALEC
  • Stock Information
  • Founded
  • NB 1987
  • ALEC 2013
  • Country
  • NB United States
  • ALEC United States
  • Employees
  • NB N/A
  • ALEC N/A
  • Industry
  • NB Metal Mining
  • ALEC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NB Basic Materials
  • ALEC Health Care
  • Exchange
  • NB Nasdaq
  • ALEC Nasdaq
  • Market Cap
  • NB 139.3M
  • ALEC 124.0M
  • IPO Year
  • NB N/A
  • ALEC 2019
  • Fundamental
  • Price
  • NB $3.08
  • ALEC $1.63
  • Analyst Decision
  • NB Strong Buy
  • ALEC Buy
  • Analyst Count
  • NB 2
  • ALEC 7
  • Target Price
  • NB $4.50
  • ALEC $4.70
  • AVG Volume (30 Days)
  • NB 1.5M
  • ALEC 535.0K
  • Earning Date
  • NB 05-08-2025
  • ALEC 08-06-2025
  • Dividend Yield
  • NB N/A
  • ALEC N/A
  • EPS Growth
  • NB N/A
  • ALEC N/A
  • EPS
  • NB N/A
  • ALEC N/A
  • Revenue
  • NB N/A
  • ALEC $88,339,000.00
  • Revenue This Year
  • NB N/A
  • ALEC N/A
  • Revenue Next Year
  • NB N/A
  • ALEC $319.82
  • P/E Ratio
  • NB N/A
  • ALEC N/A
  • Revenue Growth
  • NB N/A
  • ALEC N/A
  • 52 Week Low
  • NB $1.27
  • ALEC $0.87
  • 52 Week High
  • NB $4.15
  • ALEC $6.78
  • Technical
  • Relative Strength Index (RSI)
  • NB 59.68
  • ALEC 57.56
  • Support Level
  • NB $2.17
  • ALEC $1.41
  • Resistance Level
  • NB $2.85
  • ALEC $1.75
  • Average True Range (ATR)
  • NB 0.18
  • ALEC 0.12
  • MACD
  • NB 0.00
  • ALEC 0.01
  • Stochastic Oscillator
  • NB 94.67
  • ALEC 67.90

About NB NioCorp Developments Ltd.

NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Share on Social Networks: